CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Integrative Oncology

ONCOLOGY. Vol. 23 No. 3
INTEGRATIVE ONCOLOGY 

Vitamin D

Complementary Therapies, Herbs, and other OTC Agents

By Guest Editor Barrie Cassileth, PhD1 | March 16, 2009
1 Laurance S. Rockefeller Chair and Chief, Integrative Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York
Integrative Oncology is the synthesis of mainstream care and nonpharmacologic, evidence-based complementary therapies for the control of cancer-related physical and emotional symptoms. This month, we consider supplementation with vitamin D, which has been examined as a preventive agent and as a treatment for cancer.


SUPPLEMENT: Vitamin D

ALSO KNOWN AS: Calciferol, ergocalciferol(Drug information on ergocalciferol), calcitriol, cholecalciferol(Drug information on cholecalciferol)

USES: To treat psoriasis, scleroderma, seasonal affective disorder, and to prevent osteoporosis and cancer

BACKGROUND: Vitamin D is a fat-soluble substance found in dairy products, fish, and mushrooms. Sunlight, the major source of vitamin D for humans, promotes the endogenous synthesis of its active form. Multivitamins and supplements with various amounts of vitamin D are commercially available. The two forms used in humans are ergocalciferol (D2) and cholecalciferol (D3)—they are bioequivalent, but D3 may be preferable because it has a longer half-life.

RESEARCH: Vitamin D was shown to improve bone density and prevent fractures,[1] but such benefits were not observed in the Women’s Health Initiative (WHI) study,[2] perhaps due to the use of inadequate doses. Vitamin D effectively treats psoriasis.[3] Its ability to improve seasonal affective disorder is unclear.[4] It has also been examined as a preventive agent and as a treatment for cancer. Observational, prospective, and retrospective studies suggest that it decreases the risk of developing cancer.[5] A recent double-blind, randomized controlled trial found that supplementation with vitamin D plus calcium significantly reduced cancer incidence.[6]

Conversely, a recent large prospective study showed that, with the exception of colorectal cancer, vitamin D did not protect against cancer,[7] and a study of Finnish smokers showed that subjects with higher 25(OH)D levels were at greater risk for pancreatic cancer compared with those with lower concentrations.[8] Controlled clinical trials studying vitamin D supplementation are required to determine optimal levels for cancer prevention.

ADVERSE REACTIONS: High doses of vitamin D can cause hypercalcemia.[9] Toxicity associated with elevated serum levels of vitamin D includes depression, headache, drowsiness, weakness, calcium and bone loss, and metastatic calcification of soft tissues in the kidney, heart, blood vessels, and lungs.[10]

 DR. CASSILETH: The recommendation to minimize sun exposure to prevent skin cancer has produced a pandemic of vitamin D deficiency. Vitamin D has generated considerable interest in the past decade, as accumulating evidence from both retrospective and prospective epidemiologic studies suggests an association between vitamin D deficiency and increased risk of autoimmune, infectious, and cardiovascular diseases, as well as cancer. Vitamin D supplementation assists repletion in deficient individuals. Major medical centers typically recommend 1,000 IU/d for an average adult.

Vitamin D maintains serum calcium and phosphorus levels by regulating their absorption and excretion. It is also important for bone formation, as deficiency can cause rickets and other bone disorders, is a potent antiproliferative agent, and a pro-differentiation hormone.

Currently, the level of the major circulating form of vitamin D, 25-hydroxyvitamin D—resulting from vitamin D metabolism in the liver—is used to measure vitamin D status. Optimal concentration, including that for cancer prevention, is not yet known. Vitamin D lowers the incidence of colorectal cancer but not that of other cancers. This plus the Finnish pancreatic cancer study suggest that response to vitamin D may vary by tissue type. Additional research is needed to fully understand the mechanism of action and optimal dosing of vitamin D.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





REFERENCES
1. Rodriguez-Martinez MA, García-Cohen EC: Pharmacol Ther 93:37-49, 2002.
2. Jackson RD, LaCroix AZ, Gass M, et al: N Engl J Med 354:669-683, 2006.
3. Kragballe K: J Am Acad Dermatol 27:1001-1008, 1992.
4. Gloth FM 3rd, Alam W, Hollis B: J Nutr Health Aging 3:5-7, 1999.
5. Garland CF, Garland FC, Gorham ED, et al: Am J Public Health 96:9-18, 2006.
6. Lappe JM, Travers-Gustafson D, Davies KM, et al: Am J Clin Nutr 85:1586-1591, 2007.
7. Freedman MD, Looker AC, Chang SC, et al: J Natl Cancer Inst 99:1594-1602, 2007.
8. Stolzenberg-Solomon RZ, Vieth R, Azad A, et al: Cancer Res 66:10213-10219, 2006.
9. Koeffler HP, Hirji K, Itri L: Cancer Treat Rep 69:1399-1407, 1985.
10. Pronsky ZM: Power’s and Moore’s Food-Medication Interactions, 11th ed. Pottstown, Pa; Food Medication Interactions; 2000.


 
RELATED CONTENT

The Key to Reducing Quackery Lies in Healing Patients and Treating Their Experience
ONCOLOGY,  August 20, 2012
Quackery, Placebos, and Other Thoughts: An Integrative Oncologist’s Perspective
ONCOLOGY,  August 20, 2012
Cancer Quackery: The Persistent Popularity of Useless, Irrational 'Alternative' Treatments
ONCOLOGY,  August 20, 2012
Integrative Medicine: Not Just Garnish
ONCOLOGY Nurse Edition,  May 9, 2012
Green Tea (Camellia sinensis)
ONCOLOGY,  December 31, 2011
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • A 49-Year-Old Woman Develops Thickened and Bound-Down Skin
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Integrative Oncology
Evidence on Integrative Oncology
Guidelines on Integrative Oncology
Patient Education on Integrative Oncology
Clinical Trials on Integrative Oncology
Practical Articles on Integrative Oncology
Research and Reviews on Integrative Oncology
All "Integrative Oncology" results


CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy